Akeso Biomedical's Unattributed - IV Round

Akeso Biomedical raised a round of funding on May 18, 2018.

Akeso Biomedical is developing a new generation of compounds, known as Fe3C, with broad-spectrum activity to fight bacterial infections, and prevent foodborne illnesses. The company's technology is be…

Articles about Akeso Biomedical's Unattributed - IV Round: